SCHEMBL6446552

SCHEMBL6446552

N#Cc1c(F)c(F)c(F)c(Cl)c1F

nearest known ligand 0.43

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TRPV4 Q9HBA0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10756123 0.92 ALDH1A1 (0.46) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL6443337 0.89 MEN1 (0.48) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL1793668 0.89 MEN1 (0.48) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL28398409 0.86 MEN1 (0.46) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL10825637 0.86 MEN1 (0.46) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL5334380 0.84 MEN1 (0.43) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL5673651 0.84 ALDH1A1 (0.43) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL5674920 0.83 MEN1 (0.55) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL8047840 0.83 MEN1 (0.55) MEN1ALDH1A1TP53CYP3A4MAPT
SCHEMBL250738 0.83 TRPV4 (0.39) MEN1ALDH1A1TP53CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220119337-A1 PROCESS FOR PREPARATION OF HALOGENATED BENZYLAMINE AND INTERMEDIATES THEROF SRF LIMITED (IN) 2022-04-21 US disclosed
EP-3914582-A1 PROCESS FOR PREPARATION OF HALOGENATED BENZYLAMINE AND INTERMEDIATES THEROF SRF LIMITED (IN) 2021-12-01 EP disclosed
WO-2020152711-A1 PROCESS FOR PREPARATION OF HALOGENATED BENZYLAMINE AND INTERMEDIATES THEROF SRF LIMITED (IN) 2020-07-30 WO disclosed
EP-1233010-B1 Method for production of organic fluorine compound NIPPON CATALYTIC CHEM IND (JP) 2005-06-15 EP disclosed
EP-0899256-B1 Method for production of organic fluorine compound NIPPON CATALYTIC CHEM IND (JP) 2003-08-06 EP disclosed
EP-1233010-A1 Method for production of organic fluorine compound Nippon Shokubai Co., Ltd. (JP) 2002-08-21 EP disclosed
US-6437168-B1 FLUORINATION; EFFICIENT EXTRACTION NIPPON SHOKUBAI CO., LTD. (JP) 2002-08-20 US disclosed
US-6392084-B1 FLUORINATION OF AN ORGANO(BROMINE OR CHLORIDE) COMPOUND IN BENZONITRILE SOLVENT NIPPON SHOKUBAI CO., LTD. (JP) 2002-05-21 US disclosed
US-20020035301-A1 Method for production of aromatic fluorine compound NIPPON SHOKUBAI CO., LTD. (JP) 2002-03-21 US disclosed
EP-0899256-A2 Method for production of organic fluorine compound NIPPON SHOKUBAI CO., LTD. (JP) 1999-03-03 EP disclosed
EP-0481317-B1 Method for dechlorination and/or debromination of aromatic compounds containing fluorine with chlorine and/or bromine BAYER AG (DE) 1995-08-09 EP disclosed
US-5283378-A Process for the dechlorination and/or debromination of fluorine-and chlorine- and/or bromine-containing aromatic compounds BAYER AKTIENGESELLSCHAFT (DE) 1994-02-01 US disclosed
EP-0481317-A2 Method for dechlorination and/or debromination of aromatic compounds containing fluorine with chlorine and/or bromine BAYER AG (DE) 1992-04-22 EP disclosed
US-5079251-A Insecticides, pesticides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-01-07 US disclosed
EP-0408196-A2 Pyrazinone derivatives as insecticides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-01-16 EP disclosed
EP-0120575-B1 ORGANIC FLUORINE COMPOUNDS Nippon Shokubai Kagaku Kogyo Co., Ltd (JP) 1989-06-14 EP disclosed
US-4684734-A Method for manufacture or organic fluorine compounds NIPPON SHOKUBAI KK CO., LTD. (JP) 1987-08-04 US disclosed
EP-0120575-A1 Organic fluorine compounds Nippon Shokubai Kagaku Kogyo Co., Ltd (JP) 1984-10-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035301-A1 Method for production of aromatic fluorine compound AFF4, AFF2, AFF1 MEN1 2142/4885ALDH1A1 4338/4885TP53 1799/4885
US-20220119337-A1 PROCESS FOR PREPARATION OF HALOGENATED BENZYLAMINE AND INTERMEDIATES THEROF BTF3, BBOX1, TEAD1 MEN1 412/4885ALDH1A1 1055/4885TP53 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.